CyclosporineImmunosuppressive AgentsTacrolimusKidney TransplantationGraft RejectionMycophenolic AcidCalcineurinCyclophilin AGraft SurvivalAzathioprineDrug Therapy, CombinationTransplantation, HomologousImmunosuppressionTime FactorsTreatment OutcomeKidneySirolimusHeart TransplantationLiver TransplantationDrug MonitoringDrug Administration ScheduleAdministration, OralPrednisoneGraft vs Host DiseasePrednisoloneDrug InteractionsAnemia, AplasticAntilymphocyte SerumArea Under CurveNephrotic SyndromeMethylprednisoloneBone Marrow TransplantationKidney DiseasesGingival OvergrowthCyclophilinsCreatinineEmulsionsDermatologic AgentsRadiation DosageLethal Dose 50Adrenal Cortex HormonesRecurrenceBiological AvailabilityRats, WistarRetrospective StudiesChromatography, High Pressure LiquidMethotrexateRats, Inbred LewFollow-Up StudiesRats, Sprague-DawleyP-GlycoproteinProspective StudiesDouble-Blind MethodTissue DonorsTransplantation ImmunologyDose-Response Relationship, DrugSteroidsInjections, IntravenousRats, Inbred WFUveitisHistocompatibility TestingRadiometryTransplantationKidney Function TestsDogsInfusions, IntravenousGlomerular Filtration RateNephrosis, LipoidRadioimmunoassayOphthalmic SolutionsAcute DiseaseCapsulesAnti-Inflammatory AgentsGlomerulonephritis, MembranousHalf-LifeLiverAntibodies, MonoclonalPsoriasisDrug SubstitutionHistocompatibilityWhole-Body IrradiationDisease Models, AnimalAdministration, TopicalFluorescence Polarization ImmunoassayCytochrome P-450 CYP3AHematologic NeoplasmsPulse Therapy, DrugDose-Response Relationship, RadiationMetabolic Clearance RateTransplantation ConditioningScleritisChronic DiseaseDose FractionationLung TransplantationCyclophosphamideNFATC Transcription Factors